Dr. Agadoa discusses the efforts of the National Medical Association and AMGEN to address the disparities in healthcare for minorities with renal disease.
Renal Disease in Minority Populations
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Dr. Agadoa discusses the efforts of the National Medical Association and AMGEN to address the disparities in healthcare for minorities with renal disease.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Medical Industry Feature
Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology
<p>Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology</p>
CME/CE
FCS and SHTG: Are We Meeting the Need?
0.25 credits
<p>FCS and SHTG: Are We Meeting the Need?</p>
CME/CE Broadcast Replay
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
1.00 credits
<p>Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease</p>
CME/CE
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
0.50 credits
<p>IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement</p>
CME/CE Broadcast Replay
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
0.75 credits
<p>Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care</p>
CME/CE
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
0.50 credits
<p>New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure</p>
CME/CE
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
0.50 credits
<p><span data-contrast="auto" xml:lang="EN-US">Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow</span><span data-ccp-props='{"201341983":0,"335559739":0,"335559740":240}'> </span></p>
NeuroFrontiers
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
<p>Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?